Statins, incident Alzheimer disease, change in cognitive function, and neuropathology

Neurology
Z ArvanitakisD A Bennett

Abstract

To examine the relation of statins to incident Alzheimer disease (AD) and change in cognition and neuropathology. Participants were 929 older Catholic clergy (68.7% women, mean baseline age 74.9 years, education 18.2 years, Mini-Mental State Examination 28.5) free of dementia, enrolled in the Religious Orders Study, a longitudinal clinical-pathologic study of AD. All agreed to brain autopsy at time of death and underwent annual structured clinical evaluations, allowing for classification of AD and assessment of cognition (based on 19 neuropsychological tests). Statins were identified by direct medication inspection. Neuropathologic data were available on 262 participants. All macroscopic chronic cerebral infarctions were recorded. A measure of global AD pathology was derived from silver stain, and separate measures of amyloid and tangles were based on immunohistochemistry. We examined the relation of statins to incident AD using Cox proportional hazards, change in cognition using mixed effects models, and pathologic indices using logistic and linear regression. Statin use at baseline (12.8%) was not associated with incident AD (191 persons, up to 12 follow-up years), change in global cognition, or five separate cognitive domain...Continue Reading

Citations

Nov 16, 2011·Archives of Neurology·Nina E ShepardsonDennis J Selkoe
Mar 31, 2011·Nature Reviews. Neuroscience·Gilbert Di Paolo, Tae-Wan Kim
Nov 26, 2009·Alzheimer Disease and Associated Disorders·Marwan N SabbaghDavid Larry Sparks
May 18, 2010·Alzheimer Disease and Associated Disorders·Alberto Serrano-PozoJohn H Growdon
Sep 16, 2010·Journal of Epidemiology and Community Health·May A BeydounAlan B Zonderman
Dec 4, 2013·European Journal of Pharmacology·Simran Maggo, John C Ashton
Feb 28, 2014·BioMed Research International·Marcus O W GrimmTobias Hartmann
Feb 8, 2014·CNS Drugs·Brendan J Kelley, Stephen Glasser
Nov 3, 2012·Cholesterol·Matthias Orth, Stefano Bellosta
Nov 26, 2009·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Abhimanyu BeriSnigdha B Mahajan
Oct 20, 2010·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Elisa Biondi
Jan 17, 2012·Expert Review of Neurotherapeutics·Marwan N Sabbagh, D Larry Sparks
May 1, 2009·Expert Review of Neurotherapeutics·Alina Solomon, Miia Kivipelto
Apr 28, 2010·Expert Review of Neurotherapeutics·Joshua D Grill, Jeffrey L Cummings
Nov 9, 2012·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Zhenzhen ZhengHuifang Shang
Oct 8, 2013·Mayo Clinic Proceedings·Kristopher J SwigerSeth S Martin
Feb 20, 2009·Journal of Neuropathology and Experimental Neurology·Moran BoimelHanna Rosenmann
Mar 3, 2010·The American Journal of Medicine·Daniel ZambónMiguel A Pappolla
Feb 9, 2010·Experimental Gerontology·Rafael Luiz RechNadja Schröder
Sep 2, 2009·Neuroscience and Biobehavioral Reviews·Lee-Fay LowHenry Brodaty
May 12, 2009·Progress in Neurobiology·Peter J van der MostUlrich L M Eisel
Mar 24, 2009·Biochimie·Sabrina Florent-BéchardThierry Oster
Jul 26, 2008·Journal of the Neurological Sciences·Gregory A JichaDavid S Knopman
Jul 18, 2008·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Roy W JonesUNKNOWN LEADe investigators
Jun 16, 2009·Journal of Neurochemistry·Jacob R HascaloviciHyman M Schipper
Jul 5, 2012·Annals of the New York Academy of Sciences·Paola GambaGabriella Leonarduzzi
Nov 6, 2012·IUBMB Life·Roberta RicciarelliCinzia Domenicotti
Sep 8, 2015·European Journal of Internal Medicine·Homayoun L DaneschvarGerald W Smetana
Jul 26, 2014·Journal of Neurology·Meinie SeelenLeonard H van den Berg
Apr 15, 2015·Clinical Cardiology·Brett L WanamakerSeth S Martin
Aug 21, 2013·Neurobiology of Aging·Panayiota PapadopoulosEdith Hamel
May 15, 2016·Trends in Cardiovascular Medicine·Katherine SamarasPerminder S Sachdev
Jun 27, 2008·Experimental Gerontology·Peter van VlietRudi G J Westendorp
Apr 1, 2014·International Journal of Cardiology·Chian-Ying ChouNicole Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.